Evidence mapPaperPMID 42369365Full record

ReviewDrug design, development and therapy2026

Swarm Intelligence in Drug Discovery Applications: Unlocking Deeper Insights on the Identification and Optimization of Potential Drug Candidates.

Zhenxiang Gao, Pingjian Ding, Cerag Oguztuzun, Rong Xu

Abstract readReview
In one paragraph

Review in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhenxiang Gao *Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.
Pingjian Ding *School of Computer Science, University of South China, Hengyang, 421001, People's Republic of China.
Cerag Oguztuzun *Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.ORCID 0009-0008-3134-3379
Rong XuCenter for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.ORCID 0000-0003-3127-4795

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Swarm-based analysis technology represents a class of computational approaches inspired by biological systems, such as bees or ants, to solve complex and high-dimensional problems through the collective behavior of interacting agents. This review provides an overview of swarm intelligence methods in drug discovery, covering foundational concepts, major algorithms, and representative applications in molecular docking, drug screening, de novo molecular design, and combinatorial chemical space exploration. We summarize classical swarm-based approaches and discuss recent hybrid frameworks integrating swarm intelligence with machine learning, deep learning, and large language model (LLM)-based multi-agent systems. In addition to highlighting their potential for adaptive search and multi-objective optimization, we critically examine current limitations, including scalability, convergence reliability, parameter sensitivity, and computational cost in high-dimensional biomedical settings. We further emphasize that many emerging frameworks, particularly LLM-enhanced and multi-agent swarm systems, remain at an early stage and have not yet been extensively validated in real-world drug discovery pipelines. Overall, swarm-based methods provide flexible and interpretable strategies for complex optimization tasks, while continued advances in data integration, benchmarking, and biologically informed modeling will be important for their broader application in drug discovery.

Indexed as

Artificial IntelligenceDrug DiscoveryAlgorithmsDeep LearningDrug DesignHumansLarge Language ModelsMachine LearningMolecular Docking Simulationartificial intelligencedrug discoverylarge language modelswarm intelligence model

Identifiers

PMID42369365
PMCPMC13310069

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.